COG2

COG2 is a core subunit of the eight-subunit conserved oligomeric Golgi (COG) complex that functions as a peripheral membrane tethering factor essential for intra-Golgi retrograde vesicular trafficking, thereby maintaining the steady-state localization of resident Golgi glycosyltransferases and normal Golgi morphology (PMID:11980916, PMID:27066481). Within the complex, COG2 directly binds COG1, COG3, and COG4, and its own Golgi association depends on COG1 and is sensitive to brefeldin A; COG2 also interacts with the vesicle-tethering factor p115 to promote Golgi ribbon integrity during interphase (PMID:7962052, PMID:15047703, PMID:17274799). Loss of COG2 causes widespread defects in N-linked, O-linked, and ceramide-linked glycosylation, including mislocalization of sphingomyelin synthase SMS1 and the glycolipid sialyltransferase SialT1, leading to reduced sphingomyelin synthesis and blocked GM3 production (PMID:21047787, PMID:21080064, PMID:27066481). Biallelic COG2 mutations cause a congenital disorder of glycosylation (CDG) characterized by impaired sialylation and galactosylation and reduced COG2/COG3/COG4 protein levels (PMID:24784932).

1. 1994 High

   Identification of COG2 (LDLC/ldlCp) as a peripheral Golgi protein whose localization depends on COG1 (LDLB) established that loss of a single factor could produce pleiotropic defects in multiple medial- and trans-Golgi glycosylation pathways.

   Evidence cDNA cloning, immunofluorescence, BFA treatment, and somatic cell genetics in ldlB/ldlC CHO mutants

   PMID:7962052

   Open questions at the time

   • Identity and stoichiometry of the native complex containing ldlCp were unknown
   • Mechanism by which COG1 controls COG2 Golgi recruitment was unresolved
   • Whether ldlCp function is conserved beyond CHO cells was untested
2. 2002 High

   Biochemical purification and EM imaging revealed that COG2 is an integral subunit of an eight-subunit COG complex with a bilobed ~37-nm architecture, establishing the quaternary context in which COG2 operates.

   Evidence Co-purification, deep-etch EM, and genetic complementation of ldlB/ldlC CHO mutants

   PMID:11980916

   Open questions at the time

   • Which subunit–subunit contacts hold the complex together was unknown
   • Atomic-resolution structure of the complex was lacking
3. 2004 High

   Systematic binary interaction mapping showed that COG2 directly contacts COG1, COG3, and COG4, placing COG2 at a hub position within lobe A of the complex.

   Evidence In vitro translation and reciprocal co-immunoprecipitation of all eight COG subunit pairs

   PMID:15047703

   Open questions at the time

   • Structural basis for these interactions was not determined
   • Functional consequences of disrupting individual COG2 contacts were not tested
4. 2007 High

   Discovery that COG2 physically interacts with the vesicle-tethering factor p115 (via its HR2 domain) and that this interaction is required for Golgi ribbon reformation linked the COG complex to the broader tethering machinery and revealed cell-cycle-dependent regulation of this connection.

   Evidence Co-IP with p115 deletion mutants, Golgi morphology rescue in p115-knockdown cells, cell-cycle analysis

   PMID:17274799

   Open questions at the time

   • Whether additional COG subunits contribute to p115 interaction was not addressed
   • Mechanism of mitotic uncoupling of the p115–COG2 interaction was unexplored
5. 2010 High

   Studies in COG2-null cells demonstrated that COG2 is required not only for glycoprotein processing but also for sphingomyelin synthesis (via SMS1 Golgi retention) and glycolipid synthesis (via SialT1 Golgi localization), broadening the functional scope of the COG complex to lipid-linked glycosylation pathways.

   Evidence SM content measurement, SMS activity assays, GM3 quantification, SialT1 co-IP with COG1, and COG2 rescue transfection in ldlC CHO cells

   PMID:21047787 PMID:21080064

   Open questions at the time

   • Whether COG2 directly contacts glycosyltransferases or acts indirectly through vesicular recycling was unresolved
   • Extent of lipid glycosylation defects in human patients was unknown
6. 2014 High

   Identification of biallelic COG2 mutations in a patient with congenital disorder of glycosylation demonstrated the clinical relevance of COG2 and showed that partial loss of function destabilizes lobe A partners COG3 and COG4.

   Evidence Trio whole-exome sequencing, RT-PCR for nonsense-mediated decay, transferrin isoelectrofocusing, Western blotting of patient fibroblasts

   PMID:24784932

   Open questions at the time

   • Only a single family was reported; genotype–phenotype spectrum remained narrow
   • Whether the missense allele retains partial complex assembly was not tested structurally
7. 2016 High

   CRISPR knockout of all eight COG subunits in a uniform genetic background showed that COG2 loss produces among the most severe glycosylation and trafficking defects, confirming its central role in the complex and its non-redundancy with other subunits.

   Evidence CRISPR/Cas9 KO in HEK293T cells, flow cytometry with lectins/toxins, mass spectrometric N-glycan profiling, immunofluorescence

   PMID:27066481

   Open questions at the time

   • High-resolution structure of COG2 within the assembled complex remains unresolved
   • Cargo specificity of COG-dependent retrograde vesicles is incompletely catalogued

• The structural basis of COG2's hub role—how it simultaneously engages COG1, COG3, COG4, and p115—and the precise cargo repertoire of COG2-dependent retrograde vesicles remain open questions.
• No high-resolution structure of COG2 or the lobe A sub-complex
• Full inventory of Golgi enzymes dependent on COG2-mediated recycling is lacking
• Therapeutic strategies for COG2-CDG have not been developed